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The Clean Air Act is the basic U.S. Federal law for controlling air pollution. Under
Sections 108 and 109, primary (health) national ambient air quality standards (NAAQS)
can be set for pollutants which are ubiquitous in the ambient air. The standard-setting
process includes a comprehensive summary of scientific information on effects and
controls in criteria and control techniques, and the selection ofan appropriate standard
which, in thejudgment ofthe Administrator, protects the health ofnormal and suscepti-
ble subpopulations with an adequate margin ofsafety.
Determining the adequacy of existing NAAQS or establishing new standards requires
that the scientific information base be evaluated to assess pollutant effects on public
health. Improvements in this process can be accomplished not only through new health
effects research, butalso through improved use ofcurrently available data. The common-
alityjoiningthese twoeffortsis inthe areaofextrapolation modeling, whichis thetopic of
this paper. Extrapolation modeling involves determining the effective dose delivered to
the target organ of several species and the sensitivity ofthe target organ to that dose so
that effective pollutant concentrations can be estimated across species. This in turn
allows greater utilization of the results from animals in making judgments about the
effects in man from exposure to a given pollutant.
Integration of Human and Animal
Data
Although, in the natural situation, man is ex-
posed to a vast complex ofinteracting pollutants
which may manifest themselves in acute or
chronic disease, the protection afforded by
NAAQS ispresently based on single pollutants. It
is immensely difficult for epidemiological studies
quantitatively to identify chemicals which cause
disease because of the many confounding varia-
bles. While controlled human studies offer the
ability to relate cause and effect directly, in that
exposure patterns can be accurately controlled
and some confounding variables can be elimina-
ted, they too have deficiencies. Because safety of
the volunteer is of paramount importance,
chronic exposures cannot be performed; only lim-
ited end points such as acute responses which can
be measured with pulmonary function, clinical
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chemistry, or other noninvasive techniques, can
be studied. This restricts the evaluation ofpollu-
tant effects to acute and typically reversible ef-
fects. Thus, there has been concern about the
degree of adversity of such clinically observed
effects and, therefore, their relevance to the set-
ting of NAAQS. Of even greater concern is that
with human studies, one can never investigate
the full array ofpotential disease states induced
by air pollutants.
Animal studiespermit a complete evaluation of
disease, in that the researcher has the choice ofa
wide range ofconcentrations, exposure regimens,
chemical agents, biological parameters and ani-
mal species. Many physiological mechanisms are
common to animals and man, so it can be hypoth-
esized that if a pollutant causes a particular
health effect in several animal species, it is likely
to cause similar effects in man. However, quanti-
tatively relating effective pollutant concentra-
tions in animals to concentration responses in
man is not currently possible.
Historically, animaltoxicologyhasbeenusedto
illustrate the array of potential human effectsMILLER ET AL.
andto elucidate mechanisms. However, the Clean
Air Science Advisory Committee to EPA at a
meeting February 5-6, 1981 in Washington, DC,
recommended an increased direct utilization of
animal data in reviewing and recommending pri-
mary NAAQS. For example, currently available
quantitative chronic NO2 exposure studies have
used animals. However, the animal studies can-
not be used directly to determine the need for an
annual standard because ofa lack ofquantitative
extrapolation models. Since animal studies
clearly show that long-term exposure to NO2
causes emphysema (1-4), the impetus is clear. If
man is to be protected from such irreversible
effects, additional efforts must be undertaken to
develop extrapolation models useful inthe setting
of NAAQS. Pending availability of such models,
animal and human data can be evaluated with a
view towards increased understanding of poten-
tial effects on the public health.
A Case Study
The available evidence for considering the need
for a short-term standard for NO2 comes from
epidemiological studies in homes usinggas stoves
compared to homes using electric stoves, from
corroborative animal toxicological studies and
from clinical studies on sensitive populations.
Children in British homes with gas stoves experi-
enced an increase in respiratory illness, preva-
lence ofbronchitis and increases of"day or night
cough" and "colds going to the chest" (5, 6). How-
ever, the NO2 levels associated with these effects
cannotbe determined precisely since homes other
thanthose ofthe study subjects were investigated
(7). Thus, these studies can only provide qualita-
tive support for similar investigations.
In a study of6 US communities, children under
age 2 living in homes with gas stoves had an
increase in serious respiratory illness and a de-
crease in pulmonary function (8). This study and
another related one (9) reported NO2 levels found
in homes with gas and electric stoves. Short-term
peaks lasting minutes to hours in excess of 470
ztg/m3 (0.25 ppm) and even 940 gg/M3 (0.5 ppm)
were observed in the former. The 95th percentile
ofthe 24 hr average NO2 concentration was in the
range of 38-113 gg/m3 (0.02-0.06 ppm) for gas
stove homes and 19-94 jg/M3 (0.01-0.05 ppm) for
electric stove homes.
Major uncertainties associated with these vari-
ous epidemiologic studies were what specific
agents(s) caused the response and what exposure
level (concentration and averaging time) was as-
sociated with the reported effects. Animal stud-
ies, which were helpful in addressingthese uncer-
tainties, involved the use of an infectivity model
in which animals are exposed to NO2 or clean air
and then exposed to an aerosol ofviable microbes.
Through bacterial defenses, the normal individ-
ual is quite capable ofdefense against the estab-
lishment of hazardous microbes. Any significant
alteration in these pulmonary defenses would
prolong the life ofthe infectious agents and per-
mit their multiplication, which ultimately in the
animal model results in death. If this animal
model is to be used to reflect the toxicological
response occurring in man, then the end point for
comparison ofsuch studies should not be mortal-
ity, since today few individuals die of bacterial
pneumonias but rather should be the increased
prevalence ofrespiratory illness. Such a compari-
son is proper, since both mortality (animals) and
morbidity (man) are the consequences ofa loss in
pulmonary defenses. With the foregoing as back-
ground, the infectivity model data pertinent to
the gas stove studies will be discussed.
In studies examining the interaction between
concentration (C) and time (T) of exposure, al-
though the C x Tproduct remained constant, the
response was significantly different when C and T
were varied (10). The data indicated that concen-
tration was more important than the length of
exposure. Such data illustrate the need for ob-
taining and examining detailed monitoring data
in epidemiological studies to determine the ap-
propriate sampling time and frequency adequate
to protect health. Thus, a simple arithmetic aver-
age could not predict the response.
Since many individuals, such as the subjects in
the gas stove studies, are exposed intermittently
rather than continuously, it is important to un-
derstand and compare these different exposure
regimens. When comparing the response of ani-
mals to intermittent versus continuous exposure
to a high and a low concentration of NO2, it was
found that at the lower concentration, the con-
tinuous exposure initially produced a greater re-
sponse than the intermittent exposure, but after
approximately 100 hr of intermittent exposure,
the response was similar, regardless ofthe mode
ofexposure (10, 11). When the concentration was
increased, the effectobservedforthetwo exposure
modes was never significantly different regard-
less ofthe time period used.
These studies were expanded (12, 13) to deter-
mine responses to single and multiple exposure
spikes of various lengths as well as what effect
these spikes have when superimposed on a lower
continuous background concentration. The ratio
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mimics ratios frequently seen in urban communi-
ties. The greatest effect was seen when the short
term spikes were superimposed on a low back-
ground level of NO2. In this case, the exposed
animals were not able to recover from the harm-
ful effect of the spike, even though they spent a
more extensive period of time in an atmosphere
containing much less NO2. However, when the
animals were allowed to recover in clean air,
there was recovery. These studies indicated the
complexity involved in defining toxicological re-
sponses associated with various, but realistic, ex-
posure patterns. They confirmed that NO2 causes
significant increases in mortality, i.e., loss ofhost
defenses; however, the pattern and magnitude of
the response were affected by the specific expo-
sure regimen.
Although the gas stove studies alone provide
useful information, the animal infectivity model
data add support and elucidate significant uncer-
tainties. The animal infectivity studies show that
NO2 was probably the causative agent in the
epidemiological studies and that concentration of
NO2 is more important than length ofexposure in
increasing susceptibility to infectious pulmonary
illness. The short-term peaks observed in the gas
stove homes were likely the major causative fac-
tor in the effects observed. Examples can be de-
scribed for other NAAQS in which the large ani-
mal toxicological data base provides evidence for
potentially severe adverse effects in man. But
without extrapolation models, this information
can only be used qualitatively.
Developing Pulmonary
Extrapolation Models
There are two major components to the pulmo-
nary toxicological evaluation of the effects of
NAAQS pollutants in man and animals. First,
one must be able to estimate the dose to the
specific target region ofthe lung as a function of
exposure concentration (dosimetry). Second, for a
particular biological end point (edema, morpho-
logical change, etc.), a damage function must be
obtained which relates the effective delivered
dose to the magnitude of the biological response
observed (sensitivity). For example, if the same
dose is delivered to a target site in a mouse and a
person, is the response equivalent? Both compo-
nents are vital for extrapolation ofanimal data to
humans. And, ofcourse, an adequate health effect
data base must exist on which to make extrapola-
tions.
Dosimetry
Extrapolation begins by estimating differences
between man and experimental animals in the
ratio ofspecific tissue dose to exposure concentra-
tion. To achieve these objectives, greater empha-
sis mustbe placed upon developingmathematical
models for pollutant regional deposition in the
lung. These models should incorporate species
anatomical andventilatory differences andphysi-
cochemical properties ofthe pollutant as parame-
ters and should be based upon the factors which
govern transport and removal ofthe pollutant.
Dosimetry for Particles. For particles, the
overriding factors influencing regional respira-
torytract deposition are those based upon aerody-
namic properties, which in turn depend upon a
variety of physical properties. The aerodynamic
equivalent diameter Dae is defined as the diame-
ter of a unit density sphere which has the same
settling speed (under gravity) as the particle in
question of whatever shape and density (14).
Aerosols oftwo entirely different chemicals, such
as lead oxide and cadmium oxide, will deposit
similarly in the respiratory tract iftheir aerody-
namic characteristics (i.e., mass median aerody-
namic diameter and geometric standard devia-
tion) are the same.
When particles are inhaled, their aerodynamic
properties, combined with various anatomical
and breathing characteristics, determine their
fractional deposition in the respiratory tract.
With respect to respiratory tract deposition and
clearance ofinhaled aerosols, three regions canbe
considered: extrathoracic, the airways extending
from the nares down to the epiglottis and larynx
at the entrance to the trachea (the mouth is
included in this region during mouth breathing);
tracheobronchial region, the conducting airways
of the lung from the trachea to the terminal
bronchioles; pulmonary region, from the respira-
tory bronchioles to the alveoli (i.e., the gas-ex-
change region).
Historically, the mostwidely usedregional dep-
osition and clearance models were developed by
the International Commission on Radiological
Protection (ICRP) Task Group on Lung Dynamics
(15) at a time when the available human data
wereprimarilytotal deposition valuesforpolydis-
perse and sometimes unstable aerosols. Although
these models were not intended forbroad applica-
tion to environmental aerosols, they have been so
applied by some scientists. Currently, available
total and regional respiratory tract deposition in
humans of monodisperse insoluble, stable aero-
sols of different sizes obtained under various
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breathing conditions havebeen recently reviewed
(16).
Nose breathing and mouth breathing provide
contrasting deposition patterns for some respira-
tory tract regions. Particles ofDae about 10 jim or
larger are deposited in the extrathoracic region
during nose breathing (16). This compares to
about 65% deposition of particles of 10 limDae
under conditions of mouth breathing. On the
other hand, extrathoracic deposition of particles
smaller than about 1 gm Dae is slight for both
routes ofbreathing. The increased penetration of
larger particles deeper into the respiratory tract
with mouth breathing is reflected by experimen-
taldeposition datashowingthattracheobronchial
deposition of8-10 jimDaeparticles is greaterthan
20%. About 10% ofparticles as large as 15 ,imDae
arepredicted to enter the tracheobronchial region
during mouth breathing (17).
Inhaled particles less than about 4 ,umDae have
pulmonary deposition fractions between 20 and
70%. For mouth breathing, as compared to nose
breathing, the peak ofthe pulmonary deposition
curve shifts upward from about 2.5 ,um Dae to 3.5
jimDae (16). The peak is much lesspronounced for
nose breathing (about 25% compared to about
50% for mouth breathing), with a nearly constant
pulmonary deposition of about 20% for all sizes
between 0.1 and 4 jim Dae. Depending upon the
tidal volume and breathing frequency, pulmo-
nary deposition ofparticles 5 jim in aerodynamic
diameter can vary from 5-50%. With mouth
breathing, about 5-13% of particles 8-9 ,um in
aerodynamic diameter are deposited in the pul-
monary region.
Regionaldepositiondata ofparticles lessthan 3
,um Dae in nose-breathing rats, hamsters, and
dogs are available (18, 19). In these animal spe-
cies, the relative regional distribution ofparticles
less than 3 jim Dae during nose breathing follows
a pattern that is similar to regional deposition in
man during nose breathing. Thus, in this in-
stance, the use ofrodents or dogs in toxicological
research for extrapolation to humans entails dif-
ferences in regional deposition ofinsoluble parti-
cles lessthan 3 jimDaethat canbereconciledfrom
available data. Before similar relationships can
be determined for larger particles and other ani-
mal species, additional research must be con-
ducted.
Withregional deposition data (16) and informa-
tion on tidal volume, breathing frequency, and
lung surface area (2), an example can be given on
how dosimetric comparisons can be made from an
animal toxicological study in which rats are ex-
posed to a 0.4 jim mass median aerodynamic
diameter (MMAD) aerosol with a geometric stan-
dard deviation (ug) of 2.0. Regional deposition
data allows one to compute how much of the
aerosol mass is deposited. Then this estimate can
be adjusted for differences in ventilatory parame-
ters to obtain dosage comparisons between rats
and man. If dose is expressed in terms of micro-
grams of the aerosol per square centimeter of
lung per unit time, the pulmonary region ofman
receives approximately one-fourth of the dose of
the pulmonary region of a rat, given that both
breathethe same aerosol concentration. However,
for the rat as compared to man, about a 10-fold
greater dose is delivered to the tracheobronchial
region. Ifsensitivity to a given dose were equiva-
lent in man and rats, the toxicological results
from the rat study would be quantitatively di-
rectly extrapolatable to man. The availability of
the full range (0-15 jim Dae) of particle size re-
gional deposition data for man and several spe-
cies ofanimals is the major limiting factor which
prevents thewidespread formulation ofsuch dosi-
metric relationships.
Clearance ofdeposited particles also influences
dosimetry. The chemical solubility of the gas or
the particle is a prime determinant ofthe rate of
clearance. The more rapid the clearance, the less
time available for adverse effects at the site of
original deposition.
Dosimetry for Gases. While aerodynamic
properties provide a commonality for examining
particulate deposition, gaseous deposition is more
specific to the properties of the individual gas.
The major factors affecting the uptake ofgases in
the respiratory tract are the morphology of the
respiratory tract, the route of breathing, the
depth and rate of breathing, physicochemical
properties of the gas, the physical processes
which govern gas transport, and the physico-
chemical properties of the aqueous material on
the surface ofthe airways or gas exchange units.
Discussions of general considerations useful in
modeling respiratory tract transport and absorp-
tion ofgases are available (20-22).
Tb illustrate how to compare toxicological data
from experiments on guinea pigs and rabbits and
to predict the exposure level equivalent in man,
consider the following example. In man, rabbit
and guinea pig, the pattern of 03 deposition is
similar, with one specific area of the lung (the
respiratory bronchioles) receiving the maximal
dose (23), aprediction correlatingwell with histo-
pathological data (24-26). Suppose an experiment
has been conducted in which guinea pigs were
exposedto 2000 jig 03/m3 (1.02 ppm). Allowingfor
approximately 50% nasopharyngeal removal
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(27), this exposure level corresponds to a tracheal
03 concentration of 1000 tug/m3 (0.51 ppm). A
1000 ,ug/m3 (0.51 ppm) tracheal O3 concentration
in guinea pigs yields the same predicted respira-
tory bronchiolar dose as does a 500 ,ug/m3 (0.26
ppm) tracheal 03 concentration in rabbits (23).
This corresponds to a 420 p,g/m3 (0.21 ppm) tra-
cheal O3 concentration in man. Thus, the model
predicts that, as far as the O3 dose to the respira-
tory'bronchioles is concerned, comparable expo-
sure levels occur if guinea pigs are exposed to
2000 pRg/m3 (1.02 ppm) and rabbits to 1000 ,ug/m3
(0.51 ppm). Ifdata on nasopharyngeal removal of
03 in man were available, a comparable exposure
level for man could be predicted.
Tissue Sensitivity
Evenwhenthedosimetry is known, thebiologi-
cal response to a given dose may be different in
various species. An accurate extrapolation must,
therefore, take such potential differences into ac-
count. When accounting for species differences,
the simplest possibility is when the mechanism of
action iscommon amongspecies, butinputfactors
or repair factors affecting the magnitude of re-
sponse have graded levels across species.
For a given pollutant, the ultimate mechanism
of toxicity should be similar across species. For
example, with 03, the initiation of the reaction
with unsaturated fatty acids involves a direct
attack of03 on the carbon-carbon double bonds of
the fatty acid (28). While these fatty acids and
their double bonds are identical in all species,
there are species differences in the proportion of
classes ofthese unsaturated fatty acids. In addi-
tion, this initial 03 reaction results in the forma-
tion of reactive intermediaries. These steps are
influenced by such things asthe concentrations of
other chemicals (like levels ofvitamin E or anti-
oxidant enzymes) which also differ across species.
In addition, repair mechanisms which have a
great influence on the expression oftoxicity differ
across species. However, these factors ought not
to override the basic similarities, so that it is
feasible to develop pulmonary extrapolation
models. For example, the fact remains that when
monkeys, rats, cats, or mice are exposed to low
levels of 03, there is a sloughing ofType I alveo-
lar lining cells and a replacement by Type II cells
(29). For this type of effect, the sensitivity issue
relates to the tissue dose-response characteristics
andrelatedmechanisms across species sothatthe
human response can be predicted quantitatively.
Areas of Needed Research
Research is needed in dosimetry, sensitivity,
and health effects to meet the ultimate goals of
extrapolation. The more accurate the information
on the various components comprising extrapola-
tion models, the more quantitative the dosimetric
estimates will be. Information on the biochemical
composition, turnover and synthesis rates and
regional thickness in the mucous and surfactant
layers and the nature of the reactions of the
pollutants with the components ofthese layers is
needed.
Respiratory tract morphometric data are vital
for dosimetry models ofboth gases and particles.
The nature and structure ofthe respiratory tract
inman andanimals critically influencesthe depo-
sition of both particles and gases since the rela-
tive contributions of the mechanisms affecting
particle deposition and ofgas transport processes
vary as a result ofthis morphology. Morphomet-
ricdataare availableforsome animal species (30-
32), as well as the normal adult man (33-35), but
need to be obtained for other animal species and
for potentially susceptible human subpopula-
tions, such as children, emphysemics, etc.
In estimating pollutant concentrations respon-
sible forobservedpulmonary effects, nasopharyn-
geal removal ofthe pollutant plays an important
role. Experimental estimates of nasopharyngeal
pollutant removal serve to determine appropriate
starting concentrations when using convective-
diffusion equations to model pollutant gas trans-
port in the lower airways. Previously, upper air-
way studies on ozone (27, 36-38) sulfur dioxide
(3943) and nitrogen dioxide (40, 43) have been
conducted. However, except for SO2 (44-46) little
is known about upper airway removal in man.
Uptake during normal respiration versus exer-
cise and for differentbreathing routes needs to be
studied.
Whilethe effective axialdiffusivity in the lungs
ofman as a function ofthe mean axial gas veloc-
ity has been studied (4), this work needs to be
extended to animals. The vertices imparted by
the bifurcation angles and branching patterns in
animal lungs may result in significantly altered
diffusion coefficients in the conducting airways.
This could change tracheobronchial dose curves,
but it is not likely to influence pulmonary dose
patterns, since molecular diffusion is the domi-
nant mechanism facilitating gas exchange in the
pulmonary region.
The thickness of the mucous layer in rabbits
(47) has been used as the basis for assigning
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thickness values in other species that have been
studied thus far. Studies on mucous thickness in
man and in other laboratory animals are not
currently available and are needed before more
definitive comparisons ofconducting airway gas-
eous doses can be made.
The diffusion coefficient ofvarious gaseous pol-
lutants in mucus and surfactant needs to be es-
tablished. Since the diffusion coefficient is impor-
tant in establishing the mass flow rate of the
gaseous pollutant from the lumen into the mucus
and surfactant layer, better estimates ofthe diffu-
sion coefficients would allow more accurate pre-
dictions of absolute differences in dose between
species.
Regional deposition ofcoarse mode particles in
normal adult man and in most animal species has
not been thoroughly studied and significant im-
provement in knowledge offine particle regional
deposition in animals is also needed. To meet the
mandate of the Clean Air Act to protect poten-
tially susceptible subpopulations, deposition data
for such populations are required. These popula-
tions would include children, individuals with
chronic obstructive pulmonary disease, etc. Os-
tensibly, individuals may be at greater risk while
exercising due to increased ventilation and conse-
quently an increased dose and/or a different pat-
tern of regional deposition. Some of these latter
changes may reflect the switch from nasal to
oronasal breathing with increased ventilatory de-
mand. The influence of the varying degrees of
oronasal breathing on deposition must be studied
ifthe currently available data from experiments
using mouthpiece breathing are to be fully uti-
lized.
In determining species susceptibility, it is nec-
essary to deliver a known dose to the cells/tissue
ofseveral species and measure a variety ofbiolo-
gical responses. Major categories could include
host defense mechanisms against infectious dis-
esase, pulmonary physiology, lung biochemistry/
pharmacology, and pulmonary morphology. In
these investigations, the dose would be delivered
in two ways: in vitro so the actual dose is known,
and in vivo (inhalation) in cases where dosimetry
estimates are available and where the parameter
is not ammenable to an in vitro approach (i.e.,
pulmonary physiology).
When extrapolation models are available, they
must be applied to the existing data base. The
currently available data base consists of mostly
scientifically sound studies conducted in various
laboratories with different techniques. The prob-
lem can be visualized by examining summary
tables in the 03 Criteria Document (29). There are
almost no series ofstudies which permit sensitiv-
ity comparisons since several different species
were used. There was no commonality ofsex and
age of the animal, concentration and length of
pollutant exposure, or measurement techniques.
The entire data base for NAAQS pollutants must
be critically reviewed for gaps relevant to extrap-
olation models. For each pollutant, such a search
might reveal various health end points for which
increased knowledge would directly aid in extrap-
olation.
Although the emphasis ofthe above discussion
has been on quantitative extrapolation, qualita-
tive aspects cannot be ignored which relate to
improving knowledge ofthe mechanisms oftoxic-
ity for the most significant health effects. Much
information is available on these mechanisms, so
again the issue is refinement ofthe data base by
highly goal-oriented studies. Knowledge ofmech-
anisms is the cement that binds together the
various elements ofquantitative extrapolation.
Summary
Environmental toxicologists are confronted
with the formidable task of interpreting the
results from epidemiological, human clinical and
animal studies on air pollutants and assessing
their relevance and implications concerning pol-
lutant levels to which man can be safely exposed.
Usually, the fraction ofthe total available toxico-
logical data base represented by epidemiological
and human clinical studies is quite small com-
pared to the data available from animal studies.
This data imbalance stems from the nature and
inherent limitations of epidemiological and hu-
man clinical studies. By contrast, animal experi-
mentation provides the choice of a wide range of
concentrations, exposure regimens, chemical
agents, biological parameters and animal species.
Relating dose-response results obtained in ani-
mal studies to the human experience is currently
difficult.
Many of the above considerations can be re-
solved through the development and use of pul-
monary extrapolation models which account for
species differences in dosimetry and tissue sensi-
tivity to the pollutant and the selective improve-
ment of the health effects data base. This paper
has focused on factors which must be considered
whendeveloping suchmodels. Animal studies are
the only avenue available for investigation ofthe
full array of potential disease states induced by
airpollutants. However, without thedevelopment
and use of pulmonary extrapolation models, the
full impact ofair pollutants on the public health
cannotbe quantitatively and accurately assessed.
174ROLE OF ANIMAL TOXICOLOGY INREGULATORY DECISIONS 175
This report has been reviewed by the Health Effects Re-
search Laboratory, U.S. Environmental Protection Agency,
and approved for publication. Mention of trade names or
commercial products does not constitute endorsement or rec-
ommendation for use.
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